showing the type II activin receptor bound to a topologically distinct location on BMP as does the type II TGF-␤ Members of the transforming growth factor ␤ (TGF-␤) receptor on TGF-␤. In the BMP-receptor ternary comsuperfamily of cytokines signal through recruitment of plex model, however, there is no direct contact between their type I and type II receptors by a mechanism that the type I and II receptors, consistent with the fact that requires the bound type II receptor, a serine and threoboth types of BMP receptors bind their ligands indepennine kinase receptor, to phosphorylate a GS box region dently. . Also, in the presence thrombotic cascades, in which a fast, successive activaof the thrombomodulin effector domain, thrombin is in tion of enzymes ultimately transforms soluble fibrinogen the fast conformation, which provided further evidence into solid fibrin. The intricate pathways of these casthat the sodium switch probably is not required for the cades allow rigorous checks and bounds, resulting in alteration of thrombin's specificity from plasminogen to tight regulation, not only to prevent the loss of blood, protein C [5]. So along with the questions that remain but also to prevent the formation of inappropriate clots.
concerning the physiological relevance of the sodium Thrombin is one of the most downstream actors of switch, many questions remain concerning its structural the clotting cascades, where it cleaves fibrinogen into mechanism. fibrin to induce its coagulation. Thus, thrombin also However, new data have emerged. The paper by Huntstarts a positive feedback loop as the resulting clot furington and Esmon in this issue of Structure describes ther activates more upstream actors of the cascade. a serendipitous finding of a new, so far unknown conforThrombin's activity and concentration levels are tightly mation of a thrombin active site mutant that apparently regulated. In complex with thrombomodulin, thrombin crystallizes because of favorable crystal contacts, deswitches its specificity and instead of cleaving fibrinogen, spite being the minority conformation in solution [6]. it activates protein C, which downregulates the thrombotic Though the catalytic triad remains intact, the pockets accascade. Furthermore, thrombin is irreversibly inhibited commodating the P2, P4, and P4Ј residues of the substrate by antithrombin, a serpin that also inhibits the upstream cleavage motif close. The authors make a strong case that activator factor Xa. Each of these regulatory mechathe new conformation corresponds to the slow form of nisms serves a specific purpose: (1) at the site where thrombin, by pointing out that many observations conclotting is required, thrombin not only cleaves plasminocerning the allosteric switch agree with the reported gen, but also indirectly promotes the local activation of conformation. Nevertheless, because the reported connew thrombin molecules; (2) thrombin that has diffused formation still has a sodium ion bound in the crystal, away from the clotting area can bind to thrombomodulin, local to the sodium binding site, the reported conformaa membrane protein exposed by intact epithelial cells; tion may not fully correspond to the slow form. Apparently, (3) in complex with thrombomodulin, thrombin is preeven in the presence of sodium, thrombin's slow and fast vented from cleaving plasminogen and instead activates conformations differ very little in stability, and the balance protein C, thus indirectly preventing the local formation can be tipped by relatively weak intermolecular interacof new thrombin molecules; and (4) subsequently, estions as exist on a growing crystalline surface. caped thrombin is rounded up by antithrombin, which Huntington and Esmon point out that the residues for its activation requires a specific pentasaccharide motif that relay the allosteric switch are strictly conserved within the heparan sulfates that line the surface of epithelial among all known thrombin species. This underlines the physiological relevance of the sodium switch. However, cells.
